Page 3 - Phenomix Sciences News Today

Bariatric surgerys benefits have been well described, but endoscopic sleeve gastroplasty is relatively new, so its outcomes havent been as well described.

/PRNewswire/ -- Phenomix Sciences (Phenomix), a precision obesity biotechnology company, announces today the launch of its biobanking registry and outcomes...

Phenomix Inks Licensing Deal with Mayo Clinic for Obesity Phenotype Blood Test What You Should Know: – Today, Phenomix Sciences announced the company has signed an exclusive technology licensing agreement with Mayo Clinic for a novel blood test that accurately predicts obesity phenotypes. – The multi-level “omics” MyPhenome™ test leverages technology developed at Mayo Clinic to analyze genomics, metabolomics and hormone levels. Its AI-driven algorithmic solution identifies four ...

Health2047 Spins Out SiteBridge Research Launches to Improve Clinical Trial Access for Small and Community Physician Practices What You Should Know: – Health2047, the innovation arm of the American Medical Association, today announced the spinout of a new company, SiteBridge Research, that offers a more accessible way for a broader set of physicians and their patients to participate in clinical research. – SiteBridge Research creates a network of independent, small practice physicians to ...

Apr 1, 2021 12:02pm Phenomix Sciences blood-based test uses phenotype-driven multi-omics technology to predict responses to obesity interventions the Food and Drug Administration has approved. (vadimguzhva/GettyImages) The American Medical Association innovation subsidiary Health2047 has spun off a company that uses personalized medicine to fight obesity. Phenomix Sciences is a phenotype testing company that carries out the AMA’s mission to confront chronic diseases such as obesity. Phenomix ...

Now in its third year, the Meda Million Dollar Challenge provided $1.1 million to six BIPOC-owned startups.